186 related articles for article (PubMed ID: 35904312)
21. Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older.
Orkaby AR; Driver JA; Ho YL; Lu B; Costa L; Honerlaw J; Galloway A; Vassy JL; Forman DE; Gaziano JM; Gagnon DR; Wilson PWF; Cho K; Djousse L
JAMA; 2020 Jul; 324(1):68-78. PubMed ID: 32633800
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
[TBL] [Abstract][Full Text] [Related]
23. Association of Coronary Artery Calcium in Adults Aged 32 to 46 Years With Incident Coronary Heart Disease and Death.
Carr JJ; Jacobs DR; Terry JG; Shay CM; Sidney S; Liu K; Schreiner PJ; Lewis CE; Shikany JM; Reis JP; Goff DC
JAMA Cardiol; 2017 Apr; 2(4):391-399. PubMed ID: 28196265
[TBL] [Abstract][Full Text] [Related]
24. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.
Chew KW; Bhattacharya D; Horwich TB; Yan P; McGinnis KA; Tseng C; Freiberg MS; Currier JS; Butt AA
J Viral Hepat; 2017 Oct; 24(10):814-822. PubMed ID: 28273386
[TBL] [Abstract][Full Text] [Related]
25. Cyclic Guanosine Monophosphate and Risk of Incident Heart Failure and Other Cardiovascular Events: the ARIC Study.
Zhao D; Guallar E; Vaidya D; Ndumele CE; Ouyang P; Post WS; Lima JA; Ying W; Kass DA; Hoogeveen RC; Shah SJ; Subramanya V; Michos ED
J Am Heart Assoc; 2020 Jan; 9(2):e013966. PubMed ID: 31928156
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis.
Kavousi M; Desai CS; Ayers C; Blumenthal RS; Budoff MJ; Mahabadi AA; Ikram MA; van der Lugt A; Hofman A; Erbel R; Khera A; Geisel MH; Jöckel KH; Lehmann N; Hoffmann U; O'Donnell CJ; Massaro JM; Liu K; Möhlenkamp S; Ning H; Franco OH; Greenland P
JAMA; 2016 Nov; 316(20):2126-2134. PubMed ID: 27846641
[TBL] [Abstract][Full Text] [Related]
27. Predicting cardiovascular disease risk across the atherosclerotic disease continuum.
Poppe KK; Wells S; Jackson R; Doughty RN; Kerr AJ
Eur J Prev Cardiol; 2022 Feb; 28(18):2010-2017. PubMed ID: 33624049
[TBL] [Abstract][Full Text] [Related]
28. Development of new scores for atherosclerotic cardiovascular disease using specific medical examination items: the Suita Study.
Arafa A; Kashima R; Yasui Y; Kawachi H; Matsumoto C; Nosaka S; Teramoto M; Matsuo M; Kokubo Y
Environ Health Prev Med; 2023; 28():61. PubMed ID: 37899208
[TBL] [Abstract][Full Text] [Related]
29. Physical Activity, Parental History of Premature Coronary Heart Disease, and Incident Atherosclerotic Cardiovascular Disease in the Atherosclerosis Risk in Communities (ARIC) Study.
Florido R; Zhao D; Ndumele CE; Lutsey PL; McEvoy JW; Windham BG; Pankow JS; Guallar E; Michos ED
J Am Heart Assoc; 2016 Aug; 5(9):. PubMed ID: 27577582
[TBL] [Abstract][Full Text] [Related]
30. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
Roe MT; Li QH; Bhatt DL; Bittner VA; Diaz R; Goodman SG; Harrington RA; Jukema JW; Lopez-Jaramillo P; Lopes RD; Louie MJ; Moriarty PM; Szarek M; Vogel R; White HD; Zeiher AM; Baccara-Dinet MT; Steg PG; Schwartz GG
Circulation; 2019 Nov; 140(19):1578-1589. PubMed ID: 31475572
[TBL] [Abstract][Full Text] [Related]
31. Breast Arterial Calcification: a Novel Cardiovascular Risk Enhancer Among Postmenopausal Women.
Iribarren C; Chandra M; Lee C; Sanchez G; Sam DL; Azamian FF; Cho HM; Ding H; Wong ND; Molloi S
Circ Cardiovasc Imaging; 2022 Mar; 15(3):e013526. PubMed ID: 35290077
[TBL] [Abstract][Full Text] [Related]
32. High-Risk Atherosclerotic Cardiovascular Disease in a Real-World Employed Japanese Population: Prevalence, Cardiovascular Event Rates, and Costs.
Davis KL; Meyers J; Zhao Z; McCollam PL; Murakami M
J Atheroscler Thromb; 2015; 22(12):1287-304. PubMed ID: 26289083
[TBL] [Abstract][Full Text] [Related]
33. Serious Adverse Events Cluster in Participants Experiencing the Primary Composite Cardiovascular Endpoint: A Post Hoc Analysis of the SPRINT Trial.
Botchway A; Buhnerkempe MG; Prakash V; Al-Akchar M; Adekola B; Flack JM
Am J Hypertens; 2020 May; 33(6):528-533. PubMed ID: 31930338
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a novel 10-year cardiovascular risk prediction nomogram for the United Arab Emirates national population.
Al-Shamsi S
BMJ Open; 2022 Dec; 12(12):e064502. PubMed ID: 36581433
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular Event Rates in Statin-Treated Korean Patients with Cardiovascular Disease: Estimates from a Real-World Population Using Electronic Medical Record Data.
Kwon O; Na W; Hur J; Kim JH; Jun TJ; Kang HJ; Lee H; Kim YH
Cardiovasc Drugs Ther; 2023 Feb; 37(1):129-140. PubMed ID: 34622354
[TBL] [Abstract][Full Text] [Related]
36. ASCVD risk stratification modifies the effect of HbA1c on cardiovascular events among patients with type 2 diabetes mellitus with basic to moderate risk.
Zhang H; Qin L; Sheng CS; Niu Y; Gu H; Lu S; Yang Z; Tian J; Su Q
BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958299
[TBL] [Abstract][Full Text] [Related]
37. Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population.
Sverre E; Peersen K; Weedon-Fekjær H; Perk J; Gjertsen E; Husebye E; Gullestad L; Dammen T; Otterstad JE; Munkhaugen J
BMC Cardiovasc Disord; 2020 Feb; 20(1):61. PubMed ID: 32024471
[TBL] [Abstract][Full Text] [Related]
38. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
[TBL] [Abstract][Full Text] [Related]
39. Differences in predictors of incident heart failure according to atherosclerotic cardiovascular disease status.
Dawson LP; Carrington MJ; Haregu T; Nanayakkara S; Jennings G; Dart A; Stub D; Kaye D
ESC Heart Fail; 2023 Dec; 10(6):3398-3409. PubMed ID: 37688465
[TBL] [Abstract][Full Text] [Related]
40. Relation of Cardiovascular Events and Deaths to Low-Density Lipoprotein Cholesterol Level Among Statin-Treated Patients With Atherosclerotic Cardiovascular Disease.
Chamberlain AM; Cohen SS; Weston SA; Fox KM; Xiang P; Killian JM; Qian Y
Am J Cardiol; 2019 Jun; 123(11):1739-1744. PubMed ID: 30948001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
